R. Fróes

Prevalence, phenotype and medication for the pediatric inflammatory bowel disease population of a state in Southeastern Brazil

M. Zago-Gomes, Adalberta Lima Martins, R. Fróes, 2022, World journal of clinical pediatrics.

Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB)

D. Magro, C. Coy, R. Saad-Hossne, 2022, BMC Gastroenterology.

Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients.

A. J. Carneiro, H. D. de Souza, T. Simão, 2014, World Journal of Gastroenterology.

DISCONTINUATION RATES FOLLOWING A SWITCH FROM A REFERENCE TO A BIOSIMILAR BIOLOGIC IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.

R. Saad-Hossne, N. Queiroz, F. Teixeira, 2020, Arquivos de gastroenterologia.

Multidrug resistance 1 gene polymorphisms may determine Crohn's disease behavior in patients from Rio de Janeiro

A. J. Carneiro, R. Luiz, H. D. de Souza, 2014, Clinics.

SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).

S. Miszputen, C. Coy, R. Saad-Hossne, 2023, Arquivos de gastroenterologia.

SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).

S. Miszputen, J. Chebli, C. Coy, 2023, Arquivos de gastroenterologia.